Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update von Johnson, JA, Caudle, KE, Gong, L, Whirl‐Carrillo, M, Stein, CM, Scott, SA, Lee, MT, Gage, BF, Kimmel, SE, Perera, MA, Anderson, JL, Pirmohamed, M, Klein, TE, Limdi, NA, Cavallari, LH, Wadelius, M

Volltext

Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African‐American and European‐American Patients on Warfarin von Limdi, NA, McGwin, G, Goldstein, JA, Beasley, TM, Arnett, DK, Adler, BK, Baird, MF, Acton, RT

Volltext

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data von Klein, T E, Altman, R B, Eriksson, N, Gage, B F, Kimmel, S E, Lee, M-T M, Limdi, N A, Page, D, Roden, D M, Wagner, M J, Caldwell, M D, Johnson, J A

Volltext

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype‐Guided Antiplatelet Therapy von Harada, S, Zhou, Y, Duncan, S, Armstead, AR, Coshatt, GM, Dillon, C, Brott, BC, Willig, J, Alsip, JA, Hillegass, WB, Limdi, NA

Volltext

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting von Cavallari, LH, Beitelshees, AL, Blake, KV, Dressler, LG, Duarte, JD, Elsey, A, Eichmeyer, JN, Empey, PE, Franciosi, JP, Hicks, JK, Holmes, AM, Jeng, LJB, Lee, CR, Lima, JJ, Limdi, NA, Modlin, J, Obeng, AO, Petry, N, Pratt, VM, Skaar, TC, Tuteja, S, Voora, D, Wagner, M, Weitzel, KW, Wilke, RA, Peterson, JF, Johnson, JA

Volltext

Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update von Haaz, S., Fontaine, K. R., Cutter, G., Limdi, N., Perumean-Chaney, S., Allison, D. B.

Volltext

Efficacy of rapid IV administration of valproic acid for status epilepticus von LIMDI, N. A, SHIMPI, A. V, FAUGHT, E, GOMEZ, C. R, BURNEO, J. G

Volltext

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing von Lenzini, P, Wadelius, M, Kimmel, S, Anderson, J L, Jorgensen, A L, Pirmohamed, M, Caldwell, M D, Limdi, N, Burmester, J K, Dowd, M B, Angchaisuksiri, P, Bass, A R, Chen, J, Eriksson, N, Rane, A, Lindh, J D, Carlquist, J F, Horne, B D, Grice, G, Milligan, P E, Eby, C, Shin, J, Kim, H, Kurnik, D, Stein, C M, McMillin, G, Pendleton, R C, Berg, R L, Deloukas, P, Gage, B F

Volltext

Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy von Limdi, N.A., Wiener, H., Goldstein, J.A., Acton, R.T., Beasley, T.M.

Volltext

Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy von Dutta, S., Faught, E., Limdi, N. A.

Volltext

The Safety of Rapid Valproic Acid Infusion von Limdi, Nita A., Faught, Edward

Volltext

A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy von Goldstein, J.A., Blaisdell, J.A., Limdi, N.A.

Volltext

Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy von Limdi, N.A., Beasley, T.M., Allison, D.B., Rivers, C.A., Acton, R.T.

Volltext

263 Pharmacogenomics in people with cystic fibrosis: A personalized medicine approach von Anderson, J., Brittney, D., Giang, G., Smith, A., Lee, C., Parker, K., Searcy, H., Benner, K., Limdi, N., Guimbellot, J.

Volltext

Warfarin Pharmacogenetics von Limdi, Nita A., Veenstra, David L.

Volltext

Practical Consideration of Genotype Imputation: Sample Size, Window Size, Reference Choice, and Untyped Rate von Zhang, Boshao, Zhi, Degui, Zhang, Kui, Gao, Guimin, Limdi, Nita N, Liu, Nianjun

Volltext

Expectations, validity, and reality in pharmacogenetics von Limdi, Nita A, Veenstra, David L

Volltext

Neurotoxicity following addition of intravenous valproate to lamotrigine therapy von BURNEO, J. G, LIMDI, N, KUZNIECKY, R. I, KNOWLTON, R. C, MENDEZ, M, LAWN, N, FAUGHT, E, WELTY, T. E, PRASAD, A

Volltext

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy von Horne, Benjamin D., Lenzini, Petra A., Wadelius, Mia, Jorgensen, Andrea L., Kimmel, Stephen E., Ridker, Paul M., Eriksson, Niclas, Anderson, Jeffrey L., Pirmohamed, Munir, Limdi, Nita A., Pendleton, Robert C., McMillin, Gwendolyn A., Burmester, James K., Kurnik, Daniel, Stein, C. Michael, Caldwell, Michael D., Eby, Charles S., Rane, Anders, Lindh, Jonatan D., Shin, Jae-Gook, Kim, Ho-Sook, Angchaisuksiri, Pantep, Glynn, Robert J., Kronquist, Kathryn E., Carlquist, John F., Grice, Gloria R., Barrack, Robert L., Li, Juan, Gage, Brian F.

Volltext

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network von Duong, Benjamin Q, Arwood, Meghan J, Hicks, J Kevin, Beitelshees, Amber L, Franchi, Francesco, Houder, John T, Limdi, Nita A, Cook, Kelsey J, Owusu Obeng, Aniwaa, Petry, Natasha, Tuteja, Sony, Elsey, Amanda R, Cavallari, Larisa H, Wiisanen, Kristin

Volltext